Company attributes
Industry
B2X
CEO
Founder
AngelList URL
Pitchbook URL
Legal Name
Codexis, Inc.
Date Incorporated
2008
Number of Employees (Ranges)
51 – 200
Email Address
media@codexis.com0
Phone Number
+165042181000
Full Address
200 Penobscot Drive Redwood City, CA 94063 United States0
CIK Number
DUNS Number
129292889
IRS Number
710,872,999
Founded Date
2002
0Total Funding Amount (USD)
162,000,000
Latest Funding Round Date
December 2020
Competitors
Stock Symbol
CDXS0
Exchange
CFO
Former CEO
Latest Funding Type
Patents Assigned (Count)
20
Wellfound ID
Country
Headquarters
Other attributes
Company Operating Status
Active
SIC Code
2,860
Ticker Symbol
CDXS
Wikidata ID
Codexis was incorporated in 2002 by Maxygen to develop an enzyme engineering technology platform, completing a spin-off in 2010 as a separate publicly-listed company on the NASDAQ exchange. The company is making enzymes for companies operating in the following industries: pharmaceuticals, biotherapeutics, food & beverage, and molecular diagnostics.
Funding
Growth
On June 20, 2019 Codexis completed a growth funding round with $50 million in funding from Casdin Capital. The funding is through a private placement of Codexis common stock, and will be used to fund strategic growth initiatives for the companies activity in the synthetic biology market. The president and CEo of Codexis made the following public statement regarding Casdin Capital's investment:
The value and the versatility of Codexis’ business and engineering platform enables a diverse set of high-growth capabilities across multiple markets. Casdin has long recognized our technology and leadership capability and, with their latest investment, we have significant financial flexibility to capitalize on a variety of growth opportunities.
Timeline
No Timeline data yet.
